FISH
Oxford Gene Technology Obtains CE-IVDR Certificates for FISH Products
According to the Oxford, UK-based company, the probes are important for patient management while treating hematological cancers and prenatal conditions.
Proceeds from a recent European public offering will fund commercialization of the French company's Ikoniscope20 platform in the US and EU.
With New Partnerships, Diaceutics Works to Standardize CDx Testing Globally
The deals with three quality assessment organizations will contribute to the firm's goal of connecting pharmaceutical companies, diagnostic firms, and laboratories.
Takeda's Alunbrig Gets First-Line FDA Approval With Abbott CDx in ALK-Positive Lung Cancer
The approval was based on data showing superior efficacy for Alunbrig compared to Pfizer's Xalkori, especially in patients with brain metastasis.
The company's approach involves using both fluorescence in situ hybridization and next-generation sequencing to provide clinicians with information.
Mar 11, 2019
Enzo Biochem Fiscal Q2 Revenues Sink 26 Percent
Jan 30, 2019
FDA Clears Oxford Gene Technology FISH Probes
Sep 26, 2018
Cancer Genetics, Agilent Sign FISH Probe Supply Deal
Jun 25, 2018
Mar 9, 2018
Mar 1, 2018
Empire Genomics Inks Italian Distribution Deal
May 31, 2017
Sysmex to Acquire Oxford Gene Technology
May 30, 2013